Release Date: 23/09/16 17:31 Summary: Retraction-BRB.AX Price Sensitive: Yes Download Document 47.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%